CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer

CytoDyn (CYDY) has announced the appointment of Lauren Wilcoxen, Ph.D., to the role of Chief Operating Officer and Head of Regulatory Affairs. The appointment is scheduled to take effect on November 20, 2026. Dr. Wilcoxen joins CytoDyn from Xilio Therapeutics, where she most recently served as Senior Vice President of Regulatory Affairs. Her transition into this leadership role is expected to oversee the company's operational and regulatory strategies moving forward.

6 articles from 3 sources · updated

Coverage